0001209191-18-013734.txt : 20180227 0001209191-18-013734.hdr.sgml : 20180227 20180227103249 ACCESSION NUMBER: 0001209191-18-013734 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180222 FILED AS OF DATE: 20180227 DATE AS OF CHANGE: 20180227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Montesino Ibelis CENTRAL INDEX KEY: 0001513887 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32381 FILM NUMBER: 18643388 MAIL ADDRESS: STREET 1: 800 W. OLYMPIC BLVD., SUITE 406 CITY: LOS ANGELES STATE: X1 ZIP: 90015 FORMER NAME: FORMER CONFORMED NAME: Fleming Ibelis DATE OF NAME CHANGE: 20110224 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HERBALIFE LTD. CENTRAL INDEX KEY: 0001180262 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: P.O. BOX 309GT STREET 2: UGLAND HOUSE, SOUTH CHURCH STREET CITY: GEORGE TOWN STATE: E9 ZIP: 00000 BUSINESS PHONE: 310 410 9600 MAIL ADDRESS: STREET 1: P.O. BOX 309GT STREET 2: UGLAND HOUSE, SOUTH CHURCH STREET CITY: GEORGE TOWN STATE: E9 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: WH HOLDINGS CAYMAN ISLANDS LTD DATE OF NAME CHANGE: 20020814 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-02-22 0 0001180262 HERBALIFE LTD. HLF 0001513887 Montesino Ibelis 800 W. OLYMPIC BLVD., SUITE 406 LOS ANGELES CA 90015 0 1 0 0 SVP/Managing Dir North America Common Stock 2018-02-26 4 A 0 4634 0.00 A 4634 D Stock Appreciation Rights 30.44 2018-02-22 4 A 0 19576 0.00 A 2018-03-02 2025-03-02 Common Stock 19576 19576 D Stock Appreciation Rights 47.80 2018-02-22 4 A 0 7500 0.00 A 2018-05-07 2025-05-07 Common Stock 7500 12500 D Stock Appreciation Rights 62.51 2018-02-22 4 A 0 2687 0.00 A 2018-05-09 2026-05-09 Common Stock 2687 5375 D Stock Appreciation Rights 57.19 2018-02-22 4 A 0 2825 0.00 A 2018-02-27 2027-02-27 Common Stock 2825 2825 D Consists of restricted stock units ("RSU") under the Herbalife Ltd. 2014 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of Herbalife Ltd. common stock on vesting. This award will vest 20% each on February 26, 2019 and February 26, 2020, and 60% on February 26, 2021. On March 2, 2015, the reporting person was granted an award of 32,626 stock appreciation rights ("SARs"). The amount and timing of the vesting of these SARs is dependent upon the achievement by Herbalife Ltd. (the "Company") of certain performance criteria for each of fiscal 2015, 2016 and 2017. The performance criteria for 2017 was met, resulting in 19,576 SARs which will vest on March 2, 2018. On May 7, 2015, the reporting person was granted an award of 12,500 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2016, 2017 and 2018. The performance criteria for 2017 was met, resulting in 7,500 SARs which will vest on May 7, 2018. On May 9, 2016, the reporting person was granted an award of 13,436 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2016, 2017 and 2018. The performance criteria for 2017 was met, resulting in 2,687 SARs which will vest on May 9, 2018. On February 27, 2017, the reporting person was granted an award of 14,124 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2017, 2018 and 2019. The performance criteria for 2017 was met, resulting in 2,825 SARs which will vest on February 27, 2018. /s/ Eileen Uy, Attorney-in-Fact for Ibelis Montesino 2018-02-27